6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Court Orders Convening Scheme Meeting
Just now	Maiden Drilling Commences at Reynolds & Reitenbach Lake
Just now	Dalaroo completes Blue Lagoon project transfer
Just now	NWQ Big One Copper Site Assessment and Tenement Expansion
Just now	Walgoolan Project Update Grant of Tenement

About

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) — investor relations, events, news, and company updates on 6ix.

Latest News

Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada

Press Release Apr 24 2026

Press Release Mar 21 2026

Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept

Press Release Feb 18 2026

Financials

Revenue

₹345.83 B

Market Cap

₹1.01 T

P/E Ratio

17.87

EPS

67.93

Dividend Yield

0.66%

Community Chat

Ask AI